Thomas Richard Mclean, MD | |
4101 S 4th St, Leavenworth, KS 66048-5014 | |
(913) 682-2000 | |
Not Available |
Full Name | Thomas Richard Mclean |
---|---|
Gender | Male |
Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
Location | 4101 S 4th St, Leavenworth, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316997158 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Thomas Richard Mclean, MD 4101 S 4th St, Leavenworth, KS 66048-5014 Ph: () - | Thomas Richard Mclean, MD 4101 S 4th St, Leavenworth, KS 66048-5014 Ph: (913) 682-2000 |
News Archive
At its peak, COVID-19 drastically reduced the average human lifespan — by as much as 9 years in one U.S. state — according to a new longevity metric developed at UCLA.
Keeping our homes more tightly closed during the winter months allows indoor air pollutants to build up in higher concentrations. It presents a good opportunity to test our homes for radon, a colourless, odourless gas that is produced from the natural breakdown of uranium in rocks and soil.
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
The study of muscular system protein myostatin has been of great interest to researchers as a potential therapeutic target for people with muscular disorders. Although much is known about how myostatin affects muscle growth, there has been disagreement about what types of muscle cells it acts upon. New research from a team including Carnegie's Chen-Ming Fan and Christoph Lepper narrows down the field to one likely type of cell.
› Verified 1 days ago